J. Roesler, A. Emmendorfer, C. Steinmuller, et al., Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to mice mediates protection against systemic infections with Listeria monocytogenes and Candida albicans. International Journal of Immuno-pharmacology, Vol. 13, No. 7, 1991, p. 931.

has been cited by the following article:

• TITLE: Determination of Cichoric Acid as a Biomarker in Echinacea Purpurea Cultivated in Iran Using High Performance Liquid Chromatography

  AUTHORS: Javad Zolgharnein, Ali. Niazi, Somieh Afiuni-Zadeh, Khosrow Zamani

  KEYWORDS: Echinacea Purpurea, Cichoric Acid, TLC, HPLC, Iran

  JOURNAL NAME: Chinese Medicine, Vol.1 No.1, June 30, 2010

  ABSTRACT: Echinacea purpurea (Purple coneflower) is an immunostimulating drug, containing multiple substances. The most important substance in activity is polysaccharide, caffeic acid derivatives (cichoric acid), alkamides and glycoproteins. It is not clear yet, which substances are responsible for activity. Cichoric acid is an appropriate marker of the quality of Echinacea purpurea containing product, because it has immune stimulatory effects and it is susceptible to degradation. In this study a TLC scanner system and HPLC method has been used for identification and determination of cichoric acid in aerial parts of Echinacea purpurea. The results showed that the cichoric acid content of Echinacea purpurea cultivated in Iran is about 1.50 ± 0.65% (w/w) which is comparable with cichoric acid content in native plants. The local conditions have no significant effect on cichoric acid content as a biomarker of Echinacea purpurea quality.